share_log

港股异动 | 恩典生命科技(02112)涨超6% 此前与OLYLIFE签署战略合作框架协议 加强在大健康产业领域的合作

Changes in Hong Kong stocks | Endian Life Technology (02112) rose more than 6% before signing a strategic cooperation framework agreement with OLYLIFE to strengthen cooperation in the health industry

Zhitong Finance ·  Aug 16, 2023 21:50

Zhitong Financial APP learned that Grace Life Technology (02112) rose more than 6%. As of press time, it rose 6.52% to HK $0.49, with a turnover of HK $4.61 million.

On the news side, Grace Life Technologies previously announced that the company, through its wholly-owned subsidiary GRACE GENERATION INVESTMENT LIMITED (GGIL) and OLYLIFE INTERNATIONAL PTE.LTD (OLYLIFE), signed a Strategic Cooperation Framework Agreement on June 9, 2023, which aims to strengthen cooperation between the two sides in the field of large health industry (plant cambium stem cell platform technology project) and promote the business development of both sides. To achieve equality and mutual benefit, sharing of resources, complementary advantages and win-win development.

In the future, the two sides will give full play to each other's advantages in brand, capital, resources, technology and products, and actively explore innovative cooperative development models that are in line with the industrial development and interests of both sides. OLYLIFE will first use its extensive sales network to assist Grace Life Technology in the sales and promotion of a series of plant cambium stem cell products and technology projects.

In addition, Grace Life Technologies previously announced its annual results for the year ended December 31, 2022. The group's revenue was $32.347 million, up 35% from the same period last year; the loss attributable to shareholders was $55.74 million, down 2% from the same period last year; and the loss per share was 3.72 cents per share.

The announcement said that the increase in revenue was due to the relief of the epidemic in Malaysia and the resumption of production activities in the group's mining industry. And the new trading business lines related to biological products, personal accessories and electronic products established by the Group last year increased significantly in 2022.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment